Filing Details
- Accession Number:
- 0000899866-14-000273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-19 16:49:22
- Reporting Period:
- 2014-12-18
- Filing Date:
- 2014-12-19
- Accepted Time:
- 2014-12-19 16:49:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 899866 | Alexion Pharmaceuticals Inc | ALXN | Pharmaceutical Preparations (2834) | 133648318 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1457477 | David Hallal | C/O Alexion Pharmaceuticals, Inc 352 Knotter Drive Cheshire CT 06410 | Chief Operating Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.0001 Per Share | Disposition | 2014-12-18 | 5,494 | $182.03 | 113,122 | No | 4 | S | Indirect | Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Family Trust |
Footnotes
- The transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- This sale consists of Alexion common stock contributed by the reporting person to an exchange fund in exchange for shares of the exchange fund. The Alexion shares were valued at $182.03 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.
Billionaire Hedge Funds
